TNF and psoriasis: Tumor necrosis factor (TNF), a drug target in the treatment of inflammatory diseases such as psoriasis, was ranked 1,558th (top 8%; Exome-psoriasis) prior to and 182nd (top 0.98%; r = 0.6) post-propagation in the STRING network (Figure 6B).